Are you ready to take your innovation to the next level? The Venture Challenge is a proven 10-week program designed to turn cutting-edge research or initial ideas into solid business cases in the Life Sciences sector.
RIBOPRO, a leading technology and service provider, specializing in the development and production of mRNA and lipid nanoparticles, today proudly announced the successful closing of a Series A funding round.
Six teams have started the Venture Challenge Fall 2024! Between These starting life sciences entrepreneurs will learn everything about building and pitching a business plan.
We are thrilled to announce that iProtics has secured its first investment, receiving €350,000 from UNIIQ - Finance for the Future the Zuid-Holland innovation fund.
Predica Diagnostics B.V. is active in the field of diagnostics, prognostics and prediction of treatment response in oncology. in 2018 Predica Diagnostic participated in the Venture Challenge spring edition.
During the 20th edition of the foremost life sciences business networking event, the winner of the Venture Challenge Fall 2024 will be announced. Curious about the teams of this fall edition?
• Investment will accelerate development of a state-of-the-art vascular access device known as Dynamic AVF, to improve treatment for end-stage kidney disease patients
Venture Challenge alumnus of the spring edition 2023, Spatium Medical B.V., has successfully closed a €5 million funding round. This round includes new investors InnovationQuarter and DEMCON INVESTMENTS Fund, as well as support from existing investors: Van
Are you an early-stage CEO of an early or non-profit biotech/life sciences organisation committed to developing potentially life-changing treatments for patients?